Price T Rowe Associates Inc Precision Biosciences Inc Transaction History

Price T Rowe Associates Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$9.18 - $14.15 $5.48 Million - $8.45 Million	-596,992 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$8.07 - $12.52 $255,681 - $396,671	-31,683 Reduced 5.04%	596,992 $7.47 Million
Q1 2021 May 17, 2021	BUY	$8.57 - $15.79 $5.39 Million - $9.93 Million	628,675 New	628,675 $6.51 Million

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $802M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.